Amissa
Techstars '26Charlotte, US · 14 employees on LinkedIn · 2 known investors
Find your way into Amissa
421 people in our graph share verified history with the Amissa team — schools, employers, funds. One of them is your warm intro.
Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
Founders & leadership


Board

Investors · 2
Competitors · 6
by search overlapCompanies competing with Amissa for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $495.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Amissa do?
- Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
- Who founded Amissa?
- Amissa was founded by Sam Smith, Jon Corkey.
- Who are Amissa's investors?
- Amissa's investors include Primordial Ventures, Techstars.
- Where is Amissa headquartered?
- Amissa is headquartered in Charlotte, US.







